nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1D—Signaling Pathways—S100B—melanoma	0.000376	0.000376	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CD—melanoma	0.000374	0.000374	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—RAC1—melanoma	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EDNRB—melanoma	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FOXO4—melanoma	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HDAC2—melanoma	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCR4—melanoma	0.000371	0.000371	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GNAQ—melanoma	0.000367	0.000367	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTK2B—melanoma	0.00036	0.00036	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ERBB4—melanoma	0.00036	0.00036	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CB—melanoma	0.000359	0.000359	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN2B—melanoma	0.000357	0.000357	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CG—melanoma	0.000353	0.000353	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GAB2—melanoma	0.00035	0.00035	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNA11—melanoma	0.00035	0.00035	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FLT1—melanoma	0.000349	0.000349	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CG—melanoma	0.000345	0.000345	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CD86—melanoma	0.000345	0.000345	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCL8—melanoma	0.000345	0.000345	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SYK—melanoma	0.000345	0.000345	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EDN1—melanoma	0.000342	0.000342	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CD—melanoma	0.000342	0.000342	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NGFR—melanoma	0.000338	0.000338	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ITGAV—melanoma	0.000338	0.000338	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT3—melanoma	0.000338	0.000338	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CSF2—melanoma	0.000335	0.000335	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF1—melanoma	0.000335	0.000335	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—IL2—melanoma	0.00033	0.00033	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCR4—melanoma	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FOXO4—melanoma	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HDAC2—melanoma	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—E2F1—melanoma	0.000328	0.000328	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CB—melanoma	0.000326	0.000326	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNAQ—melanoma	0.000326	0.000326	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDGFRA—melanoma	0.000324	0.000324	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ITGB3—melanoma	0.000321	0.000321	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCA—melanoma	0.000321	0.000321	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SPP1—melanoma	0.000315	0.000315	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAP2K2—melanoma	0.000314	0.000314	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—melanoma	0.000314	0.000314	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCL8—melanoma	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SOCS1—melanoma	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAP2K1—melanoma	0.000312	0.000312	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—S100B—melanoma	0.000312	0.000312	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CD—melanoma	0.00031	0.00031	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SYK—melanoma	0.000306	0.000306	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CD—melanoma	0.000304	0.000304	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT3—melanoma	0.0003	0.0003	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ITGAV—melanoma	0.0003	0.0003	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NGFR—melanoma	0.0003	0.0003	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL2—melanoma	0.000299	0.000299	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ERBB4—melanoma	0.000299	0.000299	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TERT—melanoma	0.000298	0.000298	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CB—melanoma	0.000298	0.000298	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RAC1—melanoma	0.000297	0.000297	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN2B—melanoma	0.000296	0.000296	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CD86—melanoma	0.000286	0.000286	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCL8—melanoma	0.000286	0.000286	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HIF1A—melanoma	0.000285	0.000285	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EDN1—melanoma	0.000284	0.000284	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SOCS1—melanoma	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF1—melanoma	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CSF2—melanoma	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAP2K1—melanoma	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—S100B—melanoma	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CD—melanoma	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—IL2—melanoma	0.000274	0.000274	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KDR—melanoma	0.000273	0.000273	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—E2F1—melanoma	0.000272	0.000272	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CB—melanoma	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFRA—melanoma	0.000269	0.000269	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ITGB3—melanoma	0.000266	0.000266	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCA—melanoma	0.000266	0.000266	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ERBB4—melanoma	0.000265	0.000265	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CB—melanoma	0.000265	0.000265	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN2B—melanoma	0.000263	0.000263	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FN1—melanoma	0.000263	0.000263	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SPP1—melanoma	0.000261	0.000261	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAP2K2—melanoma	0.00026	0.00026	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCL8—melanoma	0.00026	0.00026	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH1—melanoma	0.000257	0.000257	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CD86—melanoma	0.000254	0.000254	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCL8—melanoma	0.000254	0.000254	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EDN1—melanoma	0.000252	0.000252	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CD80—melanoma	0.000252	0.000252	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—melanoma	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APC—melanoma	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KIT—melanoma	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—NRAS—melanoma	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL2—melanoma	0.000248	0.000248	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EGF—melanoma	0.000248	0.000248	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TERT—melanoma	0.000248	0.000248	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RAC1—melanoma	0.000247	0.000247	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CSF2—melanoma	0.000247	0.000247	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF1—melanoma	0.000247	0.000247	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IL2—melanoma	0.000243	0.000243	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—E2F1—melanoma	0.000241	0.000241	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK3—melanoma	0.000241	0.000241	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CB—melanoma	0.00024	0.00024	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFRA—melanoma	0.000239	0.000239	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HIF1A—melanoma	0.000237	0.000237	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ITGB3—melanoma	0.000237	0.000237	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCA—melanoma	0.000237	0.000237	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—BRAF—melanoma	0.000236	0.000236	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SPP1—melanoma	0.000232	0.000232	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAP2K2—melanoma	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCL8—melanoma	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—melanoma	0.00023	0.00023	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK1—melanoma	0.000229	0.000229	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—EGFR—melanoma	0.000229	0.000229	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KDR—melanoma	0.000226	0.000226	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAP2K1—melanoma	0.000222	0.000222	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CD—melanoma	0.000221	0.000221	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL2—melanoma	0.000221	0.000221	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TERT—melanoma	0.00022	0.00022	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RAC1—melanoma	0.000219	0.000219	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CA—melanoma	0.000219	0.000219	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FN1—melanoma	0.000218	0.000218	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—KRAS—melanoma	0.000216	0.000216	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH1—melanoma	0.000213	0.000213	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF2—melanoma	0.000212	0.000212	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HIF1A—melanoma	0.00021	0.00021	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CD80—melanoma	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—melanoma	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APC—melanoma	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KIT—melanoma	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NRAS—melanoma	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EGF—melanoma	0.000206	0.000206	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KDR—melanoma	0.000201	0.000201	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK3—melanoma	0.0002	0.0002	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CA—melanoma	0.000199	0.000199	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MDM2—melanoma	0.000198	0.000198	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—BRAF—melanoma	0.000196	0.000196	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ERBB2—melanoma	0.000195	0.000195	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FN1—melanoma	0.000194	0.000194	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CB—melanoma	0.000193	0.000193	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—melanoma	0.000191	0.000191	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK1—melanoma	0.00019	0.00019	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—EGFR—melanoma	0.00019	0.00019	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH1—melanoma	0.000189	0.000189	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CD80—melanoma	0.000186	0.000186	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APC—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KIT—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NRAS—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCL8—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAP2K1—melanoma	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HRAS—melanoma	0.000184	0.000184	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CD—melanoma	0.000183	0.000183	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EGF—melanoma	0.000183	0.000183	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CA—melanoma	0.000182	0.000182	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN1B—melanoma	0.000181	0.000181	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—KRAS—melanoma	0.00018	0.00018	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—melanoma	0.000179	0.000179	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK3—melanoma	0.000177	0.000177	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CASP3—melanoma	0.000177	0.000177	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL2—melanoma	0.000177	0.000177	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—melanoma	0.000176	0.000176	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF2—melanoma	0.000176	0.000176	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—BRAF—melanoma	0.000174	0.000174	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCND1—melanoma	0.000172	0.000172	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CTNNB1—melanoma	0.000171	0.000171	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—melanoma	0.00017	0.00017	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK1—melanoma	0.000169	0.000169	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—EGFR—melanoma	0.000169	0.000169	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP9—melanoma	0.000167	0.000167	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN1A—melanoma	0.000167	0.000167	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTEN—melanoma	0.000166	0.000166	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NFKB1—melanoma	0.000166	0.000166	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	0.000165	0.000165	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MDM2—melanoma	0.000164	0.000164	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAP2K1—melanoma	0.000164	0.000164	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CD—melanoma	0.000163	0.000163	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—melanoma	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ERBB2—melanoma	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	0.000161	0.000161	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CB—melanoma	0.00016	0.00016	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—KRAS—melanoma	0.000159	0.000159	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF2—melanoma	0.000156	0.000156	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCL8—melanoma	0.000154	0.000154	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HRAS—melanoma	0.000153	0.000153	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—melanoma	0.00015	0.00015	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	0.00015	0.00015	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STAT3—melanoma	0.000149	0.000149	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NRAS—melanoma	0.000148	0.000148	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	0.000148	0.000148	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CASP3—melanoma	0.000147	0.000147	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL2—melanoma	0.000147	0.000147	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	0.000147	0.000147	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—melanoma	0.000146	0.000146	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MDM2—melanoma	0.000146	0.000146	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ERBB2—melanoma	0.000144	0.000144	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCND1—melanoma	0.000143	0.000143	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK3—melanoma	0.000142	0.000142	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	0.000142	0.000142	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	0.000142	0.000142	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP9—melanoma	0.000139	0.000139	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MYC—melanoma	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTEN—melanoma	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NFKB1—melanoma	0.000137	0.000137	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCL8—melanoma	0.000136	0.000136	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HRAS—melanoma	0.000136	0.000136	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK1—melanoma	0.000135	0.000135	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EGFR—melanoma	0.000135	0.000135	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—melanoma	0.000135	0.000135	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	0.000133	0.000133	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	0.000132	0.000132	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CASP3—melanoma	0.000131	0.000131	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL2—melanoma	0.00013	0.00013	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—melanoma	0.00013	0.00013	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KRAS—melanoma	0.000128	0.000128	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCND1—melanoma	0.000127	0.000127	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	0.000126	0.000126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—melanoma	0.000125	0.000125	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT3—melanoma	0.000124	0.000124	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP9—melanoma	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NRAS—melanoma	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTEN—melanoma	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NFKB1—melanoma	0.000122	0.000122	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—melanoma	0.00012	0.00012	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK3—melanoma	0.000118	0.000118	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	0.000117	0.000117	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MYC—melanoma	0.000115	0.000115	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TP53—melanoma	0.000114	0.000114	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK1—melanoma	0.000112	0.000112	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EGFR—melanoma	0.000112	0.000112	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—melanoma	0.000111	0.000111	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT3—melanoma	0.00011	0.00011	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NRAS—melanoma	0.000109	0.000109	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HRAS—melanoma	0.000109	0.000109	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KRAS—melanoma	0.000106	0.000106	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK3—melanoma	0.000105	0.000105	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—melanoma	0.000104	0.000104	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MYC—melanoma	0.000102	0.000102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK1—melanoma	9.97e-05	9.97e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EGFR—melanoma	9.97e-05	9.97e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	9.74e-05	9.74e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—melanoma	9.59e-05	9.59e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TP53—melanoma	9.43e-05	9.43e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KRAS—melanoma	9.42e-05	9.42e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HRAS—melanoma	9.01e-05	9.01e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	8.65e-05	8.65e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—melanoma	8.63e-05	8.63e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TP53—melanoma	8.37e-05	8.37e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HRAS—melanoma	8.01e-05	8.01e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—melanoma	7.96e-05	7.96e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—melanoma	7.66e-05	7.66e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—melanoma	7.07e-05	7.07e-05	CbGpPWpGaD
